Plasma neopterin in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function.
We measured plasma neopterin at baseline and after oCRH and ACTH(1-24) stimulation tests in 35 unmedicated, adult major-depressive patients (mean age = 41 +/- 12 years) and in 35 normal control subjects individually matched to the patients. Neopterin is released by gamma-interferon-stimulated macrophages; because gamma-interferon is secreted by activated T-lymphocytes, elevated circulating neopterin is considered to reflect activation of the cell-mediated immune system. Plasma ACTH(1-39) and cortisol also were measured as indicators of pituitary-adrenal axis activity. Baseline plasma neopterin did not differ significantly between patients and controls (medians = 6.25 and 6.57 microg/l, respectively), but the baseline neopterin:creatinine ratio showed a trend toward lower values in the patients (P < 0.07). There was no apparent plasma neopterin change from baseline (area under the curve-AUC) following oCRH or ACTH(1-24) administration in either group of subjects. As with baseline neopterin, there was no significant patient-control difference in neopterin AUC following either hormone challenge, but there were trends toward lower neopterin:creatinine ratios in the patients following both challenges. In the patients, neither baseline neopterin nor neopterin AUCs following hormone challenge were significantly correlated with age, duration of depressive episode, lifetime number of episodes, melancholic subtype, Hamilton Depression Scale total score, Hamilton factor scores, or the Hamilton suicidality item score.
O'Toole
S M
SM
Center for Neurosciences Research, MCP-Hahnemann School of Medicine, Allegheny University of the Health Sciences, Pittsburgh, PA 15212-4772, USA.
Chiappelli
F
F
Rubin
R T
RT
D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000493:pharmacokinetics; D000328:Adult; D019540:Area Under Curve; D015415:Biomarkers; D016022:Case-Control Studies; D003346:Corticotropin-Releasing Hormone / Q000493:pharmacokinetics; D003404:Creatinine / Q000097:blood; D003866:Depressive Disorder / Q000097:blood* / Q000276:immunology / Q000503:physiopathology*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D007111:Immunity, Cellular / Q000187:drug effects / Q000502:physiology; D018655:Lymphocyte Count; D008297:Male; D016555:Matched-Pair Analysis; D008875:Middle Aged; D019798:Neopterin / Q000097:blood*; D010913:Pituitary-Adrenal System / Q000187:drug effects / Q000503:physiopathology*; D012044:Regression Analysis; D012720:Severity of Illness Index
D015415:Biomarkers; D019798:Neopterin; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D003404:Creatinine; D006854:Hydrocortisone